Compared to patients with BMS , those treated with SES and EES had a strong trend towards lower two-year rates of the primary endpoint ( HR : 0.31 [ CI : 0.11-0 .90 ] , p = 0.03 , and HR : 0.74 [ CI : 0.44-1 .24 ] , p = 0.25 ) , and of TVR ( HR : 0.58 [ CI : 0.29-1 .15 ] , p = 0.12 ) and ( HR : 0.52 [ CI : 0.34-0 .78 ] , p = 0.002 ) .